Table 1.
Model/application
|
Multiple cells (ratio)
|
Culture system
|
Advances/significance
|
Limitations
|
Ref.
|
ALF | iPSC-HEs, HUVECs, BM-MSCs (10:8:2) | 3D, Matrigel | Multi-cellular LOs with vascularization | Low reproducibility; Time-consuming | 2013[65] |
ALF | HEs, MCs, ECs (all from iPSCs) (10:8:2) | 3D, ULA | All-iPSC-based strategy | Time-consuming; High cost | 2017[16] |
ALF | iPSC endoderm cells, HUVECs, UC-MSCs (10:7:1) | 3D, ULA | LOs generated from single donor-derived cells | Low reproducibility; Time-consuming | 2018[75] |
ALF | iPSCs, HAMECs (3:1) | EB, Agarose | HAMECs improved hepatic functions | Unable to reflect the nature cellular composition of liver | 2019[102] |
Liver fibrosis | HepaRG, THP-1, hTERT-HSC | 3D, Hanging drop | LOs derived from cell lines | Functional deficiency | 2017[103] |
Liver fibrosis and steatohepatitis | PHHs, KCs, HSCs, SECs (16:2:1:1) | 3D, ULA | LOs derived from primary cell sources | Low reproducibility; High cost | 2018[104] |
Steatohepatitis | Hepatocytes, HSCs, BCs, KCs (all from iPSC) | 3D, ULA | Co-differentiation of multiple cell lineages for iPSC- LOs | Functions undetermined; Potential inter/intra-batch variability | 2019[51] |
HBV infection ex vivo | iPSC endoderm cells, HUVECs, BM- MSCs (10:7:1) | 3D, ULA | Validation of advantages of iPSC-LOs in HBV modeling | Low reproducibility; Time-consuming | 2018[15] |
Hepatic differentiation | iPSC-HEs, MSCs, HUVECs (10:2:7) | 3D, Matrigel | Platform to identify developmental paracrine signals involved in hepatocyte differentiation | Low reproducibility; Time-consuming | 2017[105] |
Hepatic differentiation | iHEPs, ECs, HSCs, cholangiocytes (10:7:2:1) | 3D, ULA | Cholangiocytes impaired the hepatic functions in LOs and were associated with the liver disease relevant phenotype | Cholangiocyte activation in LOs was unclear | 2019[106] |
Liver development and angiogenesis | Hepatocytes, BCs, ECs, HSCs (all from iPSC) | 3D, Matrigel | Engineered iPSC-LOs by programming of the gene regulatory network | Not completed for liver functions | 2021[66] |
ALF: Acute liver failure; BCs: Biliary cells; BM: Bone marrow; EB: Embryoid body; ECs: Endothelial cells; HAMECs: Human adipose microvascular endothelial cells; HBV: Hepatitis B virus; HEs: Hepatic endoderm cells; HSCs: Hepatic stellate cells; HUVECs: Human umbilical vein endothelial cells; iHEPs: Induced hepatocytes; KCs: Kupffer cells; Los: Liver organoids; MCs: Mesenchymal cells; MSCs: Mesenchymal stem cells; NPCs: Non-parenchymal cells; PHHs: Primary human hepatocytes; SECs: Sinusoidal endothelial cells; UC: Umbilical cord; ULA: Ultralow adhesion microwell plate.